These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6114997)

  • 61. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
    Thesleff S; Molgó J; Lundh H
    Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):119-27. PubMed ID: 33814
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endotoxin alters spontaneous transmitter release at the frog neuromuscular junction.
    Person RJ
    J Neurosci Res; 1977; 3(1):63-72. PubMed ID: 23437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optical monitoring of transmitter release and synaptic vesicle recycling at the frog neuromuscular junction.
    Betz WJ; Bewick GS
    J Physiol; 1993 Jan; 460():287-309. PubMed ID: 8387585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Integrins and modulation of transmitter release from motor nerve terminals by stretch.
    Chen BM; Grinnell AD
    Science; 1995 Sep; 269(5230):1578-80. PubMed ID: 7667637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The mechanisms of the recovery of nerve ending functions during the reinnervation of skeletal muscle].
    Zefirov AL; Kurtasanov RS
    Fiziol Zh Im I M Sechenova; 1995 Jan; 81(1):106-13. PubMed ID: 7489001
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Strontium and quantal release of transmitter at the neuromuscular junction.
    Dodge FA; Miledi R; Rahamimoff R
    J Physiol; 1969 Jan; 200(1):267-83. PubMed ID: 4387376
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of phorbol ester on spontaneous transmitter release at frog neuromuscular junction.
    Eusebi F; Molinaro M; Caratsch CG
    Pflugers Arch; 1986 Feb; 406(2):181-3. PubMed ID: 2870468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of ethanol on the maturation of the spontaneous transmitter release by regenerated nerve endings.
    Cuppini R
    Drug Alcohol Depend; 1989 Jan; 23(1):87-92. PubMed ID: 2563968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Precision of reinnervation of original postsynaptic sites in frog muscle after a nerve crush.
    Letinsky MS; Fischbeck KH; McMahan UJ
    J Neurocytol; 1976 Dec; 5(6):691-718. PubMed ID: 1087337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal.
    Brailoiu E; Miyamoto MD; Dun NJ
    Br J Pharmacol; 2002 Nov; 137(5):719-27. PubMed ID: 12381686
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spontaneous transmitter release at the neuromuscular junction.
    Thesleff S
    Fundam Clin Pharmacol; 1988; 2(2):89-101. PubMed ID: 2899044
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transmitter secretion varies between visualized release sites at amphibian neuromuscular junctions.
    Bennett M; Jones P; Lavidis N
    Neurosci Lett; 1986 Apr; 65(3):311-5. PubMed ID: 2872629
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin.
    Lupa MT; Tabti N
    Pflugers Arch; 1986 Jun; 406(6):636-40. PubMed ID: 2872654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interrelation between MEPP amplitude and MEPP frequency in different regions along the frog neuromuscular junction.
    Robitaille R; Tremblay JP; Grenon G
    Brain Res; 1987 Apr; 408(1-2):353-8. PubMed ID: 3036304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Barbiturates and transmitter release at the frog neuromuscular junction.
    Pincus JH; Insler NF
    Brain Res; 1981 May; 213(1):127-37. PubMed ID: 6113031
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ultrastructural correlates of naturally occurring differences in transmitter release efficacy in frog motor nerve terminals.
    Herrera AA; Grinnell AD; Wolowske B
    J Neurocytol; 1985 Apr; 14(2):193-202. PubMed ID: 2864400
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further evidence for the dynamic formation of transmitter quanta at the neuromuscular junction.
    Vautrin J; Kriebel ME; Holsapple J
    J Neurosci Res; 1992 Jun; 32(2):245-54. PubMed ID: 1357188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.